Rosalind Advisors, Inc. Q4 2025 Filing
Filed February 12, 2026
Portfolio Value
$284.5B
Holdings
42
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (42 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | DCTHDELCATH SYSTEMS, INC. | 3,300,389 | $33.0B | 11.60% | |
| 2 | YB4PSAVARA INC | 3,403,721 | $20.5B | 7.21% | |
| 3 | FRXFENNEC PHARMACEUTICALS INC | 2,613,508 | $20.1B | 7.07% | |
| 4 | XERSXERIS BIOPHARMA HOLDGS INC | 2,111,700 | $16.6B | 5.83% | |
| 5 | VRDNVIRIDIAN THERAPEUTICS INC | 450,000 | $14.0B | 4.92% | |
| 6 | MDWDMEDIWOUND LTD | 749,054 | $13.8B | 4.86% | |
| 7 | VSTMVERASTEM INC | 1,788,475 | $13.8B | 4.85% | |
| 8 | REPLREPLIMUNE GROUP INC | 1,410,497 | $13.7B | 4.82% | |
| 9 | ATYRASTRIA THERAPEUTICS INC | 1,039,080 | $13.6B | 4.78% | |
| 10 | HELPCYBIN INC | 1,657,540 | $13.6B | 4.77% | |
| 11 | EYPTEYEPOINT PHARMACEUTICALS INC | 690,000 | $12.6B | 4.43% | |
| 12 | CGONCG ONCOLOGY INC | 300,000 | $12.5B | 4.38% | |
| 13 | CYTKCYTOKINETICS INC | 195,045 | $12.4B | 4.36% | |
| 14 | XFORX4 PHARMACEUTICALS INC | 2,605,920 | $10.4B | 3.66% | |
| 15 | BRD1EURMIND MEDICINE MINDMED INC | 750,000 | $10.0B | 3.53% | |
| 16 | PRNPROFOUND MEDICAL CORP | 1,068,955 | $8.4B | 2.96% | |
| 17 | NSPRINSPIREMD INC | 3,905,743 | $7.0B | 2.44% | |
| 18 | OCULOcular Therapeutix, Inc | 400,000 | $4.9B | 1.71% | |
| 19 | AVBPARRIVENT BIOPHARMA INC | 215,871 | $4.3B | 1.53% | |
| 20 | TLPHTALPHERA INC | 3,579,273 | $4.1B | 1.43% | |
| 21 | MYOMYOMO INC | 3,839,772 | $3.5B | 1.23% | |
| 22 | QQQINVESCO QQQ TR | 450,000 | $3.0B | 1.06% | Put |
| 23 | PYPDPOLYPID LTD | 696,556 | $3.0B | 1.06% | |
| 24 | OKURONKURE THERAPEUTICS INC | 730,488 | $2.1B | 0.74% | |
| 25 | SPYSPDR S&P 500 ETF TR | 510,000 | $1.9B | 0.66% | Put |
| 26 | AVXLANAVEX LIFE SCIENCES CORP | 1,168,600 | $1.9B | 0.66% | Put |
| 27 | RGNTREGENTIS BIOMATERIALS LTD | 251,510 | $1.7B | 0.60% | |
| 28 | LVLNSPDR SERIES TRUST | 1,937,600 | $1.3B | 0.47% | Put |
| 29 | TRVITREVI THERAPEUTICS INC | 100,000 | $1.3B | 0.44% | |
| 30 | AQLTISHARES TR | 200,000 | $1.1B | 0.39% | Put |
| 31 | KURAKURA ONCOLOGY INC | 100,000 | $1.0B | 0.37% | |
| 32 | NRXSNEURAXIS INC | 286,138 | $1.0B | 0.37% | |
| 33 | GUTSFRACTYL HEALTH INC | 385,731 | $848.0M | 0.30% | |
| 34 | BFRIBIOFRONTERA INC | 1,140,764 | $650.0M | 0.23% | |
| 35 | AVBPARRIVENT BIOPHARMA INC | 107,900 | $539.0M | 0.19% | Call |
| 36 | VSTMVERASTEM INC | 268,600 | $159.0M | 0.06% | Call |
| 37 | QUREUNIQURE NV | 100,000 | $95.0M | 0.03% | Call |
| 38 | REPLREPLIMUNE GROUP INC | 230,900 | $11.0M | 0.00% | Call |
| 39 | VKTXVIKING THERAPEUTICS INC | 100,000 | $2.0M | 0.00% | Call |
| 40 | REPLREPLIMUNE GROUP INC | 264,700 | $0 | 0.00% | Put |
| 41 | RZLTREZOLUTE INC | 263,100 | $0 | 0.00% | Call |
| 42 | VTGNVISTAGEN THERAPEUTICS INC | 493,400 | $0 | 0.00% | Call |